ABCD Staging + Body Composition: Your Shortcut to Smarter Decisions

Join endocrinologist Dr. Karl Nadolsky for a practical look at the 2025 AACE Algorithm redefining obesity as Adiposity-Based Chronic Disease (ABCD).

This case-based webinar explores how to diagnose, stratify, and treat ABCD using a complication-centric approach—bringing precision and personalization to everyday obesity care.

The new AACE guidance underscores that ABCD is a complex, chronic disease requiring long-term, individualized treatment focused on health improvement rather than weight alone. Learn how clinical staging and body composition data can guide therapy intensity, support shared decision-making, and help identify the right interventions—whether lifestyle, pharmacologic, or surgical.

You’ll learn how to:

• Understand the 2025 AACE Algorithm and how it redefines obesity as Adiposity-Based Chronic Disease (ABCD).
• Apply clinical staging and body composition assessment to identify adiposity patterns that drive metabolic and functional risk.
• Integrate complication-centric care by aligning treatment intensity and intervention choice—lifestyle, pharmacologic, or surgical—with disease stage and severity.
• Implement biopsychosocial, stigma-free approach that promotes equality of care and supports shared decision-making in obesity management.
• Use case studies to visualize how clinical staging and body composition data are applied in real-world practice to personalize obesity treatment.

You’ll also gain insights into the role of second-generation incretin-based medications, which achieve significant weight reduction with meaningful clinical benefits, and how endocrinologists are applying these tools within a biopsychosocial model that reduces bias, supports equality of care, and prioritizes real-world outcomes